Tech Company Financing Transactions

KaloBios Pharmaceuticals Funding Round

KaloBios Pharmaceuticals, operating out of Brisbane, secured $20 million in investment from Lehman Brothers Venture Partners, 5AM Ventures and Alloy Ventures.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

1000 Marina Blvd. 250
Brisbane, CA 94005
USA

Phone

(650) 243-3100

Website

www.kalobios.com

Email Address

[email protected]

Overview

KaloBios (NASDAQ: KBIO) is a vertically integrated therapeutic antibody company using its proprietary antibody engineering, humaneering and expression technologies for the development of a pipeline of antibody therapeutics.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Cameron Durrant

        

Browse more venture capital transactions:

Prev: 7/23/2007: Grockit venture capital transaction
Next: 7/23/2007: Cloud9 Analytics venture capital transaction

Share this article

About Our VC Transactions Data

Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary